Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine vs placebo in bipolar I disorder (maintenance, 36 weeks)
CTR20132354Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lamotrigine in bipolar I disorder, sponsored by GSK. Started Feb 2014; status: completed.
02
Drugs
lamotrigine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on CTR20132354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132354.